Two recent studies suggest value of intermittent hormone therapy
Tuesday, March 31st, 2009 Posted in hormone therapy | No Comments »Two European studies that have just been published appear to validate the long-term concept of intermittent hormone therapy (IHT). The first study was designed to determine whether intermittent therapy is associated with a shorter time to progression The authors of this study ...
Alcohol and prostate cancer
Monday, March 30th, 2009 Posted in prostate cancer risks | No Comments »Men who drink two or more alcoholic drinks a day are 20 per cent more likely to get prostate cancer, the first research to link the two has found. The risk is likely to confuse Australian men who have previously been ...
To be or not to be PSA tested
Saturday, March 28th, 2009 Posted in prostate cancer diagnosis | No Comments »Two major studies found last week that the PSA blood test used to screen for prostate cancer doesn't save lives and leads many men to risky and unnecessary treatment, However, the two studies in the New England Journal of Medicine, one ...
Factors predicting of risk of erectile dysfunction after prostatectomy
Friday, March 27th, 2009 Posted in prostatectomy | No Comments »A recent study has reported data on factors predicting the preservation of erectile function in men undergoing open radical retropubic prostatectomy (RRP). The study data suggest that several factors existing prior to surgery are potential indicators of the preservatuion of potency ...
Oily fish lowers prostrate cancer risk
Wednesday, March 25th, 2009 Posted in prostate cancer risks | No Comments »A diet rich in omega-3 fatty acids found in fish such as herring, salmon and mackerel could prevent development of the deadly disease, concluded a recent study. The new research suggests that eating oily fish just once a week can help ...
Sarcosine may distinguish slow-growing prostate cancers from those aggressive
Wednesday, March 25th, 2009 Posted in prostate cancer diagnosis | No Comments »Sarcosine may distinguish slow-growing prostate cancers from those likely to spread and become lethal. Conveniently, sarcosine can be identified in urine, a less invasive test than the blood analysis needed for the standard prostate-specific antigen (PSA), a protein produced by ...
Gene-guided treatment for prostate cancer
Tuesday, March 24th, 2009 Posted in prostate cancer | No Comments »Doctors are starting to attempt gene-guided treatment for men with advanced disease. It's an approach already offered in treating breast and certain other cancers. The new prostate work is a small initial step at catching up. And it targets the men ...
Pathological outcomes and criteria for active surveillance protocols
Tuesday, March 24th, 2009 Posted in prostatectomy, watchful waiting | No Comments »A recent study has used the University of California San Francisco database to evaluate the pathological outcomes of men meeting published criteria for active surveillance who elected immediate radical prostatectomy to assess the risk of under-grading and under-staging in candidates for ...
Prostatectomy improves cancer survival
Monday, March 23rd, 2009 Posted in prostatectomy | No Comments »A recent research, known as the Scandinavian Prostate Cancer Group Study 4, found radical prostatectomy -- prostate removal -- improved prostate cancer survival, when compared with watchful waiting. Lars Holmberg of Uppsala, Sweden, said the study was the first randomized trial ...
Photoselective vaporization prostatectomy
Sunday, March 22nd, 2009 Posted in prostatectomy | No Comments »A group at the University of Oklahoma has reported the incidence, prevention, and management of perioperative adverse events in patients treated with transurethral photoselective vaporization prostatectomy (PVP) using the side-firing GreenLight HPS laser. Among other, the authors report the following outcome ...